Variables | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Tumor deposits | ||||
No | Ref. | Ref. | ||
Yes | 2.522 (2.016–3.156) | < 0.001 | 1.096 (0.839–1.433) | 0.500 |
TD + PLNs | ||||
0(N0) | Ref. | Ref. | ||
1–2(reN1) | 1.994 (1.511–2.631) | < 0.001 | 1.176 (0.757–1.828) | 0.470 |
3+(reN2) | 3.309 (2.625–4.171) | < 0.001 | 1.637 (1.063–2.521) | 0.025 |
Age (years) | ||||
<65 | Ref. | Ref. | ||
≥ 65 | 1.525 (1.241–1.875) | < 0.001 | 1.548 (1.237–1.936) | < 0.001 |
BMI | ||||
<25 | Ref. | |||
≥ 25 | 0.985 (0.764–1.27) | 0.905 | ||
Tumor size (cm) | ||||
≤ 2.70 | Ref. | Ref. | ||
>2.70 | 1.49 (1.112–1.997) | 0.008 | 1.113 (0.817–1.515) | 0.498 |
Obstruction before surgery | ||||
Absent | Ref. | Ref. | ||
present | 1.839 (1.422–2.379) | < 0.001 | 1.164 (0.872–1.554) | 0.303 |
Sex | ||||
Male | Ref. | |||
Female | 0.95 (0.773–1.167) | 0.625 | ||
Family history of cancer | ||||
No | Ref. | |||
Yes | 1.055 (0.752–1.482) | 0.755 | ||
Post radiotherapy | ||||
No | Ref. | |||
Yes | 0.965 (0.615–1.514) | 0.877 | ||
Chemotherapy | ||||
No | Ref. | |||
Yes | 0.936 (0.765–1.145) | 0.518 | ||
Vascular invasion | ||||
Absent | Ref. | Ref. | ||
Present | 2.304 (1.844–2.88) | < 0.001 | 1.137 (0.874–1.478) | 0.338 |
perineural invasion | ||||
Absent | Ref. | Ref. | ||
Present | 2.541 (2.054–3.143) | < 0.001 | 1.690 (1.328–2.151) | < 0.001 |
Histological grade | ||||
Well | Ref. | Ref. | ||
Moderately | 1.086 (0.8-1.474) | 0.596 | 0.847 (0.620–1.156) | 0.296 |
Poorly | 1.569 (1.09–2.258) | 0.015 | 0.959 (0.659–1.397) | 0.829 |
TNM stage | ||||
I | Ref. | Ref. | ||
II | 2.515 (1.474–4.291) | 0.001 | 1.915 (1.103–3.323) | 0.021 |
III | 5.032 (3.016–8.394) | < 0.001 | 2.370 (1.248–4.501) | 0.008 |
IV | 15.665 (9.226–26.6) | < 0.001 | 7.955 (4.280-14.785) | < 0.001 |
Primary tumor location | ||||
Right colon | Ref. | |||
Left colon | 1.207 (0.911-1.6) | 0.189 | ||
Rectum | 0.891 (0.693–1.145) | 0.366 | ||
ASA | ||||
1 | Ref. | |||
2 | 1.029 (0.383–2.763) | 0.955 | ||
3 | 1.164 (0.426–3.182) | 0.767 | ||
4 | 1.812 (0.653–5.025) | 0.254 | ||
Previous history of abdominal surgery | ||||
No | Ref. | |||
Yes | 0.852 (0.649–1.119) | 0.250 | ||
Neoadjuvant chemotherapy | ||||
No | Ref. | |||
Yes | 1.321 (0.88–1.982) | 0.179 | ||
Preoperative comorbidities | ||||
Any preoperative comorbidities | ||||
No | Ref. | Ref. | ||
Yes | 1.386 (1.12–1.716) | 0.003 | 1.176 (0.742–1.863) | 0.489 |
Cardiovascular disease | ||||
No | Ref. | Ref. | ||
Yes | 1.403 (1.122–1.755) | 0.003 | 1.035 (0.638–1.679) | 0.890 |
Cerebrovascular disease | ||||
No | Ref. | |||
Yes | 1.334 (0.711-2.5) | 0.369 | ||
COPD | ||||
No | Ref. | |||
Yes | 1.357 (0.78–2.36) | 0.279 | ||
Diabetes | ||||
No | Ref. | |||
Yes | 0.963 (0.655–1.416) | 0.849 | ||
Hematological diseases | ||||
No | Ref. | |||
Yes | 2.082 (0.519–8.361) | 0.301 | ||
CEA (ng/mL) | ||||
Normal | Ref. | Ref. | ||
High | 2.038 (1.665–2.495) | < 0.001 | 1.305 (1.046–1.629) | 0.019 |
CA19-9 (kU/L) | ||||
Normal | Ref. | Ref. | ||
High | 2.006 (1.594–2.523) | < 0.001 | 1.257 (0.983–1.609) | 0.068 |
CA72-4 (U/mL) | ||||
Normal | Ref. | |||
High | 1.298 (0.987–1.708) | 0.062 | ||
CA125 (U/mL) | ||||
Normal | Ref. | Ref. | ||
High | 2.156 (1.644–2.827) | < 0.001 | 1.430 (1.054–1.939) | 0.021 |